Principal Financial Group Inc. lifted its stake in shares of Heska Corp (NASDAQ:HSKA) by 3.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 57,404 shares of the medical research company’s stock after buying an additional 1,807 shares during the period. Principal Financial Group Inc. owned about 0.76% of Heska worth $4,942,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in HSKA. We Are One Seven LLC purchased a new position in Heska in the fourth quarter worth $86,000. LS Investment Advisors LLC boosted its position in Heska by 30.1% in the fourth quarter. LS Investment Advisors LLC now owns 1,133 shares of the medical research company’s stock worth $98,000 after purchasing an additional 262 shares during the last quarter. Bank of Montreal Can boosted its position in Heska by 11.7% in the fourth quarter. Bank of Montreal Can now owns 1,876 shares of the medical research company’s stock worth $162,000 after purchasing an additional 196 shares during the last quarter. Virtu Financial LLC purchased a new position in Heska in the third quarter worth $223,000. Finally, Oregon Public Employees Retirement Fund purchased a new position in Heska in the fourth quarter worth $224,000. 84.72% of the stock is currently owned by institutional investors.
Several research firms have weighed in on HSKA. Sidoti cut Heska from a “buy” rating to a “neutral” rating in a research report on Tuesday, February 26th. BidaskClub raised Heska from a “sell” rating to a “hold” rating in a research report on Wednesday, March 27th. Zacks Investment Research cut Heska from a “buy” rating to a “hold” rating in a research report on Friday, February 8th. B. Riley cut their price objective on Heska from $93.00 to $87.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 27th. Finally, Benchmark cut Heska from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $109.00.
HSKA stock opened at $75.88 on Monday. Heska Corp has a 1-year low of $71.60 and a 1-year high of $114.50. The firm has a market capitalization of $600.80 million, a price-to-earnings ratio of 53.44 and a beta of 0.80.
Heska (NASDAQ:HSKA) last posted its quarterly earnings data on Tuesday, February 26th. The medical research company reported $0.44 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.76 by ($0.32). Heska had a return on equity of 9.87% and a net margin of 4.59%.
In other Heska news, COO Jason A. Napolitano sold 4,829 shares of the business’s stock in a transaction on Wednesday, January 16th. The stock was sold at an average price of $90.91, for a total value of $439,004.39. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last 90 days, insiders sold 27,329 shares of company stock worth $2,638,829. Corporate insiders own 14.00% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Principal Financial Group Inc. Has $4.94 Million Position in Heska Corp (HSKA)” was posted by Macon Daily and is the property of of Macon Daily. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://macondaily.com/2019/04/15/principal-financial-group-inc-has-4-94-million-position-in-heska-corp-hska.html.
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps.
Further Reading: How Do Mutual Funds Work?
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.